102 related articles for article (PubMed ID: 33277842)
1. Molecular evaluation of a multiplex methylation panel for epigenetic analysis of FNAB samples from Greek patients with suspicious breast lesions.
Vavoulidis E; Petousis S; Margioula Siarkou C; Mareti E; Kougioumtsidou N; Symeonidou M; Loufopoulos PD; Daniilidis A; Chatzikyriakidou A; Lambropoulos A; Zepiridis L; Dinas K
J BUON; 2020; 25(5):2244-2254. PubMed ID: 33277842
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation patterns of RAR-β2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions.
Kougioumtsidou N; Vavoulidis E; Nasioutziki M; Symeonidou M; Pratilas GC; Mareti E; Petousis S; Chatzikyriakidou A; Grimbizis G; Theodoridis T; Miliaras D; Dinas K; Zepiridis L
Diagn Cytopathol; 2021 Jan; 49(1):153-164. PubMed ID: 32530576
[TBL] [Abstract][Full Text] [Related]
3. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
Jeronimo C; Monteiro P; Henrique R; Dinis-Ribeiro M; Costa I; Costa VL; Filipe L; Carvalho AL; Hoque MO; Pais I; Leal C; Teixeira MR; Sidransky D
Breast Cancer Res Treat; 2008 May; 109(1):27-34. PubMed ID: 17549626
[TBL] [Abstract][Full Text] [Related]
4. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
5. Identification of breast cancer DNA methylation markers optimized for fine-needle aspiration samples.
Bu D; Lewis CM; Sarode V; Chen M; Ma X; Lazorwitz AM; Rao R; Leitch M; Moldrem A; Andrews V; Gazdar A; Euhus D
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2212-21. PubMed ID: 24089458
[TBL] [Abstract][Full Text] [Related]
6. High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions.
Martins AT; Monteiro P; Ramalho-Carvalho J; Costa VL; Dinis-Ribeiro M; Leal C; Henrique R; Jerónimo C
Breast Cancer Res Treat; 2011 Aug; 129(1):1-9. PubMed ID: 20842524
[TBL] [Abstract][Full Text] [Related]
7. Detection of gene promoter hypermethylation in fine needle washings from breast lesions.
Jerónimo C; Costa I; Martins MC; Monteiro P; Lisboa S; Palmeira C; Henrique R; Teixeira MR; Lopes C
Clin Cancer Res; 2003 Aug; 9(9):3413-7. PubMed ID: 12960130
[TBL] [Abstract][Full Text] [Related]
8. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer.
Fackler MJ; McVeigh M; Mehrotra J; Blum MA; Lange J; Lapides A; Garrett E; Argani P; Sukumar S
Cancer Res; 2004 Jul; 64(13):4442-52. PubMed ID: 15231653
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients.
Cho YH; Yazici H; Wu HC; Terry MB; Gonzalez K; Qu M; Dalay N; Santella RM
Anticancer Res; 2010 Jul; 30(7):2489-96. PubMed ID: 20682973
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation in benign breast epithelium in relation to age and breast cancer risk.
Euhus DM; Bu D; Milchgrub S; Xie XJ; Bian A; Leitch AM; Lewis CM
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1051-9. PubMed ID: 18483325
[TBL] [Abstract][Full Text] [Related]
11. [Detection of free tumor-related DNA in the serum of breast cancer patients].
Zhang JJ; Ouyang T; Wan WH; Deng GR
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation Markers for Breast Cancer Detection in the Developing World.
Downs BM; Mercado-Rodriguez C; Cimino-Mathews A; Chen C; Yuan JP; Van Den Berg E; Cope LM; Schmitt F; Tse GM; Ali SZ; Meir-Levi D; Sood R; Li J; Richardson AL; Mosunjac MB; Rizzo M; Tulac S; Kocmond KJ; de Guzman T; Lai EW; Rhees B; Bates M; Wolff AC; Gabrielson E; Harvey SC; Umbricht CB; Visvanathan K; Fackler MJ; Sukumar S
Clin Cancer Res; 2019 Nov; 25(21):6357-6367. PubMed ID: 31300453
[TBL] [Abstract][Full Text] [Related]
13. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
[TBL] [Abstract][Full Text] [Related]
14. CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients.
Debouki-Joudi S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Cancer Biomark; 2017; 18(2):133-141. PubMed ID: 27983523
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
17. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
[TBL] [Abstract][Full Text] [Related]
18. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma.
Eloubeidi MA; Jhala D; Chhieng DC; Chen VK; Eltoum I; Vickers S; Mel Wilcox C; Jhala N
Cancer; 2003 Oct; 99(5):285-92. PubMed ID: 14579295
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype.
Van der Auwera I; Van Laere SJ; Van den Bosch SM; Van den Eynden GG; Trinh BX; van Dam PA; Colpaert CG; van Engeland M; Van Marck EA; Vermeulen PB; Dirix LY
Br J Cancer; 2008 Nov; 99(10):1735-42. PubMed ID: 18841156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]